Physical and chemical stability of palonosetron HCl in 4 infusion solutions

Annals of Pharmacotherapy

Volumn 38, Issue 10, 2004, Pages 1608-1611

  Trissel, Lawrence A ^a   Xu, Quanyun A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Compatibility; Palonosetron; Stability

Indexed keywords

DILUENT; GLUCOSE; INFUSION FLUID; PALONOSETRON; RINGER LACTATE SOLUTION; SEROTONIN 3 ANTAGONIST; SODIUM CHLORIDE;

ARTICLE; CHEMOTHERAPY INDUCED EMESIS; DILUTION; DRUG STABILITY; EVALUATION; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW TEMPERATURE; NAUSEA; PARTICULATE MATTER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ROOM TEMPERATURE; TEMPERATURE SENSITIVITY; TURBIDIMETRY;

ANTIEMETICS; DRUG INCOMPATIBILITY; DRUG STABILITY; DRUG STORAGE; GLUCOSE; INFUSIONS, INTRAVENOUS; ISOQUINOLINES; ISOTONIC SOLUTIONS; PHARMACEUTICAL SOLUTIONS; QUINUCLIDINES; SODIUM CHLORIDE;

EID: 4644267055     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D509     Document Type: Article

References (6)

1. Package insert. Aloxi (palonosetron HCl). Bloomington, MN: MGI Pharma, Inc., July 2003.
2. Stacher G. Palonosetron (Helsinn). Curr Opin Investig Drugs 2002;3: 1502-7.
3. 3 receptor antagonist, in vivo. Br J Pharmacol 1995;114:860-6.
4. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm 1992;49:1716-9.
5. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993;50:300-4.
6. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993; 50:2359-63.